The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients With Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial-Reference-Cited by-同舟云学术

The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients With Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial

Published:2021-10-15 Issue:11 Volume:64 Page:1321-1330
ISSN:0012-3706
Container-title:Diseases of the Colon & Rectum
language:en
Short-container-title:

Author:

Xie Yumo,Lin Jinxin,Wang Xiaolin,Wang Puning,Zhuang Zhuokai,Zou Qi,Cai Du,Huang Zenghong,Bai Liangliang,Tang Guannan,Huang Meijin,Wang Jianping,Yu Huichuan,Luo Yanxin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,General Medicine

Reference31 articles.

1. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.;Kapiteijn;N Engl J Med,2001

2. Preoperative versus postoperative chemoradiotherapy for rectal cancer.;Sauer;N Engl J Med,2004

3. A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence.;Kusters;Ann Surg,2009

4. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection.;Kim;Ann Surg Oncol,2008

5. Can chemoradiation allow for omission of lateral pelvic node dissection for locally advanced rectal cancer?;Kim;J Surg Oncol,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Generative Adversarial Network (GAN)-based Three-dimensional Rectal Cancer Pathological Complete Response Prediction Framework;2023-11-15

2. Accurate tumor segmentation and treatment outcome prediction with DeepTOP;Radiotherapy and Oncology;2023-06

3. Clinical atlas of rectal cancer highlights the barriers and insufficient interventions underlying the unfavorable outcomes in older patients;Heliyon;2023-05

4. Prevalent Pseudoprogression and Pseudoresidue in Patients With Rectal Cancer Treated With Neoadjuvant Immune Checkpoint Inhibitors;Journal of the National Comprehensive Cancer Network;2023-02

5. Clinical spectrum of rectal cancer identifies hallmarks of early‐onset patients and next‐generation treatment strategies;Cancer Medicine;2022-08-05